Jonathan Schechter - 30 Apr 2024 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Director
Signature
/s/ Jonathan L. Schechter
Issuer symbol
PMCB
Transactions as of
30 Apr 2024
Net transactions value
$0
Form type
4
Filing time
17 Jul 2024, 16:58:49 UTC
Previous filing
10 Apr 2024
Next filing
07 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMCB Stock Option (Right to Buy) Award $0 +38,009 $0.000000 38,009 30 Apr 2024 Common Stock 38,009 $2.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter.